435 related articles for article (PubMed ID: 18767951)
1. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.
Murshid A; Gong J; Calderwood SK
Expert Rev Vaccines; 2008 Sep; 7(7):1019-30. PubMed ID: 18767951
[TBL] [Abstract][Full Text] [Related]
2. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.
Ménoret A; Chandawarkar R
Semin Oncol; 1998 Dec; 25(6):654-60. PubMed ID: 9865680
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein vaccines: from bench to bedside.
Binder RJ
Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in heat shock protein-based cancer vaccines.
Wang HH; Mao CY; Teng LS; Cao J
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein-based cancer vaccines.
Oki Y; Younes A
Expert Rev Vaccines; 2004 Aug; 3(4):403-11. PubMed ID: 15270645
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory functions of membrane-bound and exported heat shock protein 70.
Radons J; Multhoff G
Exerc Immunol Rev; 2005; 11():17-33. PubMed ID: 16385841
[TBL] [Abstract][Full Text] [Related]
7. The role of heat shock proteins and their receptors in the activation of the immune system.
Singh-Jasuja H; Hilf N; Arnold-Schild D; Schild H
Biol Chem; 2001 Apr; 382(4):629-36. PubMed ID: 11405225
[TBL] [Abstract][Full Text] [Related]
8. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
[TBL] [Abstract][Full Text] [Related]
9. Scavenger receptors and heat-shock protein-mediated antigen cross-presentation.
Delneste Y
Biochem Soc Trans; 2004 Aug; 32(Pt 4):633-5. PubMed ID: 15270694
[TBL] [Abstract][Full Text] [Related]
10. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q
Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260
[TBL] [Abstract][Full Text] [Related]
11. Heat-shock proteins as powerful weapons in vaccine development.
Bolhassani A; Rafati S
Expert Rev Vaccines; 2008 Oct; 7(8):1185-99. PubMed ID: 18844593
[TBL] [Abstract][Full Text] [Related]
12. Current ideas about applications of heat shock proteins in vaccine design and immunotherapy.
Wang XY; Li Y; Yang G; Subjeck JR
Int J Hyperthermia; 2005 Dec; 21(8):717-22. PubMed ID: 16338854
[TBL] [Abstract][Full Text] [Related]
13. Secreted heat shock protein gp96-Ig: an innovative vaccine approach.
Strbo N; Podack ER
Am J Reprod Immunol; 2008 May; 59(5):407-16. PubMed ID: 18405311
[TBL] [Abstract][Full Text] [Related]
14. A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine.
Huang XF; Ren W; Rollins L; Pittman P; Shah M; Shen L; Gu Q; Strube R; Hu F; Chen SY
Cancer Res; 2003 Nov; 63(21):7321-9. PubMed ID: 14612530
[TBL] [Abstract][Full Text] [Related]
15. Cancer immunotherapy: stress proteins and hyperthermia.
Manjili MH; Wang XY; Park J; Macdonald IJ; Li Y; Van Schie RC; Subjeck JR
Int J Hyperthermia; 2002; 18(6):506-20. PubMed ID: 12537751
[TBL] [Abstract][Full Text] [Related]
16. Heat shock proteins: to present or not, that is the question.
Gullo CA; Teoh G
Immunol Lett; 2004 Jun; 94(1-2):1-10. PubMed ID: 15234529
[TBL] [Abstract][Full Text] [Related]
17. Hsp-based tumor vaccines: state-of-the-art and future directions.
Takakura Y; Takemoto S; Nishikawa M
Curr Opin Mol Ther; 2007 Aug; 9(4):385-91. PubMed ID: 17694451
[TBL] [Abstract][Full Text] [Related]
18. Hsp receptors: the cases of identity and mistaken identity.
Binder RJ
Curr Opin Mol Ther; 2009 Feb; 11(1):62-71. PubMed ID: 19169961
[TBL] [Abstract][Full Text] [Related]
19. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.
Calderwood SK; Theriault JR; Gong J
Eur J Immunol; 2005 Sep; 35(9):2518-27. PubMed ID: 16144035
[TBL] [Abstract][Full Text] [Related]
20. Heat shock proteins and immunity: application of hyperthermia for immunomodulation.
Torigoe T; Tamura Y; Sato N
Int J Hyperthermia; 2009 Dec; 25(8):610-6. PubMed ID: 20021222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
